Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2023?

211 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104,661,494
Total 13F shares: 81,758,941
Share change: +5,439,765
Total reported value: $2,069,347,401
Put/Call ratio: 47%
Price per share: $25.31
Number of holders: 211
Value change: +$120,257,967
Number of buys: 124
Number of sells: 96

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 761330109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital World Investors	13F	Company	9.6%	10,076,101	$324,551,213	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	5.9%	6,139,064	$197,739,254	—	31 Mar 2023	13F
Palo Alto Investors LP	13F	Company	5%	5,270,209	$169,753,432	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	4.9%	5,164,157	$166,338,000	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	4.4%	4,599,745	$148,157,786	—	31 Mar 2023	13F
Polar Capital Holdings Plc	13F	Company	4%	4,167,842	$134,246,191	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	2.2%	2,291,911	$73,822,453	—	31 Mar 2023	13F
FRANKLIN RESOURCES INC	13F	Company	2.2%	2,274,491	$73,261,357	—	31 Mar 2023	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	1.9%	2,020,981	$65,096,000	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.9%	1,978,557	$63,729,321	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	1.9%	1,947,763	$62,737,446	—	31 Mar 2023	13F
FMR LLC	13F	Company	1.8%	1,845,232	$59,434,923	—	31 Mar 2023	13F
JENNISON ASSOCIATES LLC	13F	Company	1.6%	1,633,305	$52,608,757	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.5%	1,596,514	$51,423,738	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	1.5%	1,549,500	$49,909,395	—	31 Mar 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	1.5%	1,537,250	$49,514,822	—	31 Mar 2023	13F
Jericho Capital Asset Management L.P.	13F	Company	1.4%	1,438,669	$46,339,528	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.3%	1,374,338	$44,267,427	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.1%	1,141,160	$36,756,763	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1%	1,098,290	$35,375,921	—	31 Mar 2023	13F
BAMCO INC /NY/	13F	Company	1%	1,069,483	$34,448,047	—	31 Mar 2023	13F
Holocene Advisors, LP	13F	Company	0.89%	936,415	$30,161,927	—	31 Mar 2023	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.77%	809,176	$26,063,559	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.77%	806,100	$25,964,480	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.7%	733,976	$23,641,368	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.58%	607,335	$19,562,260	—	31 Mar 2023	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.57%	598,685	$19,283,644	—	31 Mar 2023	13F
Essex Woodlands Management, Inc.	13F	Company	0.44%	457,085	$14,722,708	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.38%	402,282	$12,958,000	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.3%	309,379	$9,965,097	—	31 Mar 2023	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.29%	306,877	$9,884,508	—	31 Mar 2023	13F
HighTower Advisors, LLC	13F	Company	0.29%	305,259	$9,830,000	—	31 Mar 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.29%	305,181	$9,829,880	—	31 Mar 2023	13F
GREAT LAKES ADVISORS, LLC	13F	Company	0.29%	299,901	$9,659,810	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.28%	290,000	$9,340,899	—	31 Mar 2023	13F
SEI INVESTMENTS CO	13F	Company	0.27%	286,151	$9,216,956	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.27%	280,982	$9,050,430	—	31 Mar 2023	13F
Walleye Capital LLC	13F	Company	0.27%	280,362	$9,030,460	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.27%	277,935	$8,952,286	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.26%	274,799	$8,851,276	—	31 Mar 2023	13F
PUBLIC SECTOR PENSION INVESTMENT BOARD	13F	Company	0.24%	254,000	$8,181,340	—	31 Mar 2023	13F
Ghost Tree Capital, LLC	13F	Company	0.24%	250,000	$8,053,000	—	31 Mar 2023	13F
Integral Health Asset Management, LLC	13F	Company	0.24%	250,000	$8,052,500	—	31 Mar 2023	13F
Granahan Investment Management, LLC	13F	Company	0.23%	243,462	$7,841,911	—	31 Mar 2023	13F
LORD, ABBETT & CO. LLC	13F	Company	0.22%	231,776	$7,465,000	—	31 Mar 2023	13F
CIBC Asset Management Inc	13F	Company	0.22%	226,668	$7,300,976	—	31 Mar 2023	13F
Rhenman & Partners Asset Management AB	13F	Company	0.22%	230,000	$7,159,900	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	0.21%	221,566	$7,136,641	—	31 Mar 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.19%	194,911	$6,278,083	—	31 Mar 2023	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.17%	183,000	$5,888,940	—	31 Mar 2023	13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q2 2023

As of 30 Jun 2023, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 211 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,758,941 shares. The largest 10 holders included Capital World Investors, BlackRock Inc., Palo Alto Investors LP, JPMORGAN CHASE & CO, VANGUARD GROUP INC, Polar Capital Holdings Plc, Thrivent Financial for Lutherans, ALLIANCEBERNSTEIN L.P., FRANKLIN RESOURCES INC, and STATE STREET CORP. This page lists 211 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

215

Q2 2023 holders

211

Holder diff

-4

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.